Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.

Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, Pascual JM, Hirano M, Stacpoole PW, DiMauro S, De Vivo DC.

Neurology. 2006 Feb 14;66(3):324-30.

PMID:
16476929
[PubMed - indexed for MEDLINE]
2.

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.

Anselm IA, Darras BT.

Neurology. 2006 Oct 10;67(7):1313; author reply 1313. No abstract available.

PMID:
17030784
[PubMed - indexed for MEDLINE]
3.

Nerve conduction changes in patients with mitochondrial diseases treated with dichloroacetate.

Spruijt L, Naviaux RK, McGowan KA, Nyhan WL, Sheean G, Haas RH, Barshop BA.

Muscle Nerve. 2001 Jul;24(7):916-24.

PMID:
11410919
[PubMed - indexed for MEDLINE]
4.

Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS.

Mori M, Yamagata T, Goto T, Saito S, Momoi MY.

Brain Dev. 2004 Oct;26(7):453-8.

PMID:
15351081
[PubMed - indexed for MEDLINE]
5.

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.

Savolainen H.

Neurology. 2006 Jul 11;67(1):184; author reply 184. No abstract available.

PMID:
16832115
[PubMed - indexed for MEDLINE]
6.

Effects of dichloroacetate in three patients with MELAS.

Saitoh S, Momoi MY, Yamagata T, Mori Y, Imai M.

Neurology. 1998 Feb;50(2):531-4.

PMID:
9484392
[PubMed - indexed for MEDLINE]
7.

Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children.

Stacpoole PW, Kerr DS, Barnes C, Bunch ST, Carney PR, Fennell EM, Felitsyn NM, Gilmore RL, Greer M, Henderson GN, Hutson AD, Neiberger RE, O'Brien RG, Perkins LA, Quisling RG, Shroads AL, Shuster JJ, Silverstein JH, Theriaque DW, Valenstein E.

Pediatrics. 2006 May;117(5):1519-31.

PMID:
16651305
[PubMed - indexed for MEDLINE]
Free Article
8.

Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.

Kurlemann G, Paetzke I, Möller H, Masur H, Schuierer G, Weglage J, Koch HG.

Eur J Pediatr. 1995 Nov;154(11):928-32.

PMID:
8582409
[PubMed - indexed for MEDLINE]
9.

[Dichloroacetate treatment for adult patients with mitochondrial disease].

Oishi K, Yoshioka M, Ozawa R, Yamamoto T, Oya Y, Ogawa M, Kawai M.

Rinsho Shinkeigaku. 2003 Apr;43(4):154-61. Japanese.

PMID:
12892050
[PubMed - indexed for MEDLINE]
10.

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.

Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, Tritschler HJ, Mehnert H.

Free Radic Res. 1999 Sep;31(3):171-9.

PMID:
10499773
[PubMed - indexed for MEDLINE]
11.

Cerebral lactic acidosis correlates with neurological impairment in MELAS.

Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, Mao X, Shanske S, Hirano M, DiMauro S, De Vivo DC.

Neurology. 2004 Apr 27;62(8):1297-302.

PMID:
15111665
[PubMed - indexed for MEDLINE]
12.

Effects of chronic lithium treatment on the peripheral nervous system.

Faravelli C, Di Bernardo M, Ricca V, Benvenuti P, Bartelli M, Ronchi O.

J Clin Psychiatry. 1999 May;60(5):306-10.

PMID:
10362438
[PubMed - indexed for MEDLINE]
13.

Trial of dichloroacetate in MELAS: toxicity overshadows the assessment of potential benefit.

Schaefer AM.

Neurology. 2006 Feb 14;66(3):302-3. No abstract available.

PMID:
16476925
[PubMed - indexed for MEDLINE]
14.

Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children.

Agbenyega T, Planche T, Bedu-Addo G, Ansong D, Owusu-Ofori A, Bhattaram VA, Nagaraja NV, Shroads AL, Henderson GN, Hutson AD, Derendorf H, Krishna S, Stacpoole PW.

J Clin Pharmacol. 2003 Apr;43(4):386-96.

PMID:
12723459
[PubMed - indexed for MEDLINE]
15.

Magnetic resonance spectroscopy: use in monitoring MELAS treatment.

Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D.

Arch Neurol. 1998 Jun;55(6):849-52.

PMID:
9626777
[PubMed - indexed for MEDLINE]
16.

Nerve conduction abnormalities in patients with MELAS and the A3243G mutation.

Kaufmann P, Pascual JM, Anziska Y, Gooch CL, Engelstad K, Jhung S, DiMauro S, De Vivo DC.

Arch Neurol. 2006 May;63(5):746-8.

PMID:
16682545
[PubMed - indexed for MEDLINE]
17.

Platelet mitochondrial evaluation during cytochrome c and dichloroacetate treatments of MELAS.

Nakano K, Tarashima M, Tachikawa E, Noda N, Nakayama T, Sasaki K, Mizoguchi E, Matsuzaki M, Osawa M.

Mitochondrion. 2005 Dec;5(6):426-33. Epub 2005 Nov 14.

PMID:
16290150
[PubMed - indexed for MEDLINE]
18.

Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders.

De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL.

Neurology. 1995 Jun;45(6):1193-8.

PMID:
7783888
[PubMed - indexed for MEDLINE]
19.

Peripheral neuropathy in genetic mitochondrial diseases.

Stickler DE, Valenstein E, Neiberger RE, Perkins LA, Carney PR, Shuster JJ, Theriaque DW, Stacpoole PW.

Pediatr Neurol. 2006 Feb;34(2):127-31.

PMID:
16458825
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk